Screening and semiquantitative analysis of drugs and drugs of abuse in human serum samples using gas chromatography-mass spectrometry

被引:0
作者
Maresova, Vera [1 ]
Chadt, Jiri [1 ,2 ]
Novakova, Eva [1 ]
机构
[1] Charles Univ Prague, Fac Med 1, Inst Forens Med & Toxicol, Prague 12801 2, Czech Republic
[2] Acad Sci Czech Republ, Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic
关键词
gas chromatography-mass spectrometry; screening; analysis; drugs of abuse; drugs;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: The purpose of this study is to develop the gas chromatographic-mass spectrometric method (GC-MS) for screening and semiquantification of drugs and drugs of abuse in human serum. METHOD: GC-MS method after liquid-liquid extraction (LLE) and derivatization with N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) is presented for screening as well as identification and semiquantification of the most frequently used drugs and drugs of abuse in human serum. RESULTS: Bovine serum spiked with ephedrine (EPHE), 3,4-methylenedioxymethamphetamine (MDMA), guaifenesin (GUAIF), tramadol (TRAM), phenobarbital (PHENO), amitriptyline (AMITR), cocaine (COCA), mirtazapine (MIRTA), dothiepin (DOTH), citalopram (CITAL), clomipramine (CLOMI), bromazepam (BMZPM), diazepam (DZPM), codeine (COD), morphine (MORPH), levomepromazine (LEVO), zolpidem (ZOLP), clozapine (CLOZP), alprazolam (ALPZM) was used for the recovery and repeatability study and for preparation of calibration curves of individual compounds or their TMS derivatives. Recoveries were tested on concentration levels 0.05, 0.1 and 0.5 mu g/mL (n=6) and established in range 72.0-98.0%. Repeatabilities expressed as relative standard deviations (RSDs) measured at concentration levels 0.05, 0.1 and 0.5 mu g/mL (n=6) were lower than 10.0%. The calibration curves for analytes or their TMS derivatives were linear in concentration range 0.025-2.000 mu g/mL (except EPHE 2TMS, MDMA TMS, MORPH 2TMS, BMZPM TMS, ALPZM) with correlation coefficients exceeding 0.99. The limit of quantification (LOQ) for analytes used for evaluation Study was 0.025 mu g/mL (except analytes mentioned above). CONCLUSIONS: The GC-MS method presented here is allowing screening, identification and semiquantification of the most commonly encountered drugs and drugs of abuse in human serum and can be successfully applied to analysis of real samples from clinical and forensic toxicology cases.
引用
收藏
页码:749 / 754
页数:6
相关论文
共 28 条
  • [1] Chromatographic screening techniques in systematic toxicological analysis
    Drummer, OH
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1999, 733 (1-2): : 27 - 45
  • [2] Simultaneous screening for 238 drugs in blood by liquid chromatography-ionspray tandem mass spectrometry with multiple-reaction monitoring
    Gergov, M
    Ojanperä, I
    Vuori, E
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 795 (01): : 41 - 53
  • [3] Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection
    Gunnar, T
    Mykkänen, S
    Ariniemi, K
    Lillsunde, P
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 806 (02): : 205 - 219
  • [4] Rapid screening for and simultaneous semiquantitative analysis of thirty abused drugs in human urine samples using gas chromatography-mass spectrometry
    Ishida, Tomomi
    Kudo, Keiko
    Inoue, Hiromasa
    Tsuji, Akiko
    Kojima, Takashi
    Ikeda, Noriaki
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2006, 30 (07) : 468 - 477
  • [5] Comprehensive drug screening in blood for detecting abused drugs or drugs potentially hazardous for traffic safety
    Lillsunde, P
    Michelson, L
    Forsstrom, T
    Korte, T
    Schultz, E
    Ariniemi, K
    Portman, M
    Sihvonen, ML
    Seppala, T
    [J]. FORENSIC SCIENCE INTERNATIONAL, 1996, 77 (03) : 191 - 210
  • [6] Marescaux J, 2005, EJC SUPPL, V3, P27
  • [7] MARESOVA V, 2000, NEURO ENDOCRINOL S2, V27, P121
  • [8] Comparison of a preliminary procedure for the general unknown screening of drugs and toxic compounds using a quadrupole-linear ion-trap mass spectrometer with a liquid chromatography-mass spectrometry reference technique
    Marquet, P
    Saint-Marcoux, F
    Gamble, TN
    Leblanc, JCY
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 789 (01): : 9 - 18
  • [9] Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology
    Maurer, Hans H.
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2007, 388 (07) : 1315 - 1325
  • [10] Hyphenated mass spectrometric techniques - indispensable tools in clinical and forensic toxicology and in doping control
    Maurer, Hans H.
    [J]. JOURNAL OF MASS SPECTROMETRY, 2006, 41 (11): : 1399 - 1413